Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

7.76CAD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$7.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,413
52-wk High
$8.65
52-wk Low
$5.68

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $689.24
Shares Outstanding(Mil.): 83.54
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -1.70 -- --
ROI: -60.83 9.00 14.96
ROE: -70.80 10.14 16.53

Earnings vs. Estimates